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SUMMARY – Multiple sclerosis (MS) is one of the most common diseases of the central nervous 
system and usually occurs at the age when people would be expected to be in the prime of their sexu-
al lives. In everyday practice, sexual dysfunction is underestimated because clinicians mostly concen-
trate on the classic neurologic defi cits and often overlook symptoms that can seriously aff ect the 
quality of life. Our study included 98 patients (42 men and 56 women, mean age 35±12 years) with 
relapse from our MS register, with established diagnosis of relapsing remitting multiple sclerosis ac-
cording to McDonald criteria. Patients completed the questionnaires (Sexual Satisfaction Scale, SSS 
and Beck Depression Scale BDS), and underwent neurological assessment (Expanded Disability 
 Status Scale, EDSS). All patients were in the group with EDSS 2 to 4 points (mobile patients). Th ere 
was no statistically signifi cant diff erence in BDS and SSS values according to EDSS score. Correla-
tion coeffi  cients were calculated (BDS and SSS) for men (p=0.42) and women (p=0.44), yielding 
positive correlation. Th ere was no statistically signifi cant diff erence in BDS and SSS values according 
to gender, disease duration or immunomodulatory therapy. In our group of patients, despite low EDSS 
score (fully ambulatory without aid, self suffi  cient patients) we found positive correlation between 
sexual dysfunction and depression, showing that even in such patients the quality of life can be 
 decreased. In conclusion, sexual dysfunction and depression are mostly under-recognized by neurolo-
gists because they are not part of routine testing; therefore, some additional questionnaires should be 
used in the evaluation in MS patients, even those with low EDSS score, in order to improve their 
quality of life.
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Introduction
Multiple sclerosis (MS) is a chronic, infl ammatory, 
demyelinating disorder of the central nervous system 
(CNS) characterized by episodic and progressive neu-
rologic dysfunction resulting from infl ammatory, auto-
immune and neurodegenerative processes. According 
to McDonald MS criteria (introduced in 2001, revised 
in 2005 and 2010), MS can be divided into four clini-
cal subtypes: relapsing remitting, secondary progres-
sive, primary progressive, and progressive relapsing1.
Although multiple sclerosis has historically been 
considered primarily aff ecting the CNS white matter, 
recent pathologic and imaging studies have established 
that demyelinated lesions are also commonly found in 
the cortical gray matter of MS patients. Lesions are 
disseminated throughout the CNS, but have a pre-
dilection for optic nerves, subpial spinal cord, brain 
stem, cerebellum, juxtacortical and periventricular 
white matter regions. Histologically, several processes 
drive the formation of MS plaques: infl ammation, my-
elin breakdown, astrogliosis, oligodendrocyte injury, 
neurodegeneration and remyelination1,2.
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Th e normal male sexual response cycle can be di-
vided into libido (sexual desire), erection, ejaculation, 
orgasm and detumescence. In female, sexual response 
cycle has four elements, i.e. libido, arousal, orgasm and 
satisfaction. Th e integrity of the sexual response cycle 
is essential to human sexual response and functioning, 
and any damage may result in sexual dysfunction (SD).
Sexual arousal begins in the CNS, the brain sends 
messages to the sexual organs along the nerves run-
ning through the spinal cord (descending pathways), 
as well as receiving information from genital organs 
(ascending pathways). If MS damages these pathways, 
sexual response, including arousal and orgasm, can be 
directly aff ected (direct physical infl uence on SD). 
Sexual problems also stem from MS symptoms such as 
chronic pain, fatigue or spasticity, as well as dysfunc-
tion of urinary system (frequency, urgency, inconti-
nence and obstructive symptoms) as indirect physical 
infl uence on SD. Also, it is of great importance to bear 
in mind that emotions are the result of complex func-
tional circuits in the brain including interactions of the 
cortical, subcortical structures and limbic system. Sex-
ual dysfunction can also arise from psychological fac-
tors relating to self-esteem and mood changes as a 
consequence of decreased quality of life and social 
functioning as emotional and cultural infl uence on SD. 
In large studies, depression was the most frequent SD 
comorbidity in MS patients3-5.
Th e prevalence of SD in the general population is 
31% in men and 43% in women. Multiple sclerosis is 
associated with an increased incidence of SD, present 
in 50%-75% of men and 40%-74% of women. Th e rate 
of major depressive disorder (MDD) in MS patients 
was found to be from 36% to 54% during lifetime. Th e 
syndrome refers to a collection of signs and symptoms 
underlain by low mood and inability to enjoy life as 
before. Th is change can be accompanied by a number 
of vegetative features (altered sleep, appetite, etc.) and 
distorted beliefs (feelings of guilt, worthlessness, life is 
not worth living, etc.). Both SD and depression are 
very often under-recognized, but have considerable 
impact on the patient quality of life. Th erefore, in the 
evaluation of patients with MS, it is of great impor-
tance to pay attention not only to functional defi cit, 
but also to mood changes, SD and quality of life6-11.
Due to the complexity and multifactorial nature of 
SD and its clinical manifestations, multidisciplinary 
approach is of great importance in MS patients, in-
cluding neurologist, physical therapist, psychiatrist, 
urologist and educated nurses.
Patients and Methods
Th e present study included 98 patients aged 18-60 
years from our Neurology Department MS register. 
All patients had established diagnosis of relapsing re-
mitting multiple sclerosis according to McDonald cri-
teria with EDSS score 0-4 (fully ambulatory patients). 
Patients completed the questionnaires (Sexual Satis-
faction Scale, SSS and Beck Depression Scale, BDS), 
and underwent neurological assessment (Expanded 
Disability Status Scale, EDSS). Before establishment 
of the MS diagnosis, patients had no psychiatric diag-
nosis or treatment. Patients were not taking antide-
pressants and there was no statistically signifi cant dif-
ference in taking other symptomatic therapy (pain, 
spasms, bladder and sphincter control).
Th e Sexual Satisfaction scale is based on the Sexual 
History Form (Nowinski and LoPiccolo, 1979). Four 
items from the Sexual History Form were selected to 
provide an indicator of overall sexual adjustment. 
Th ese items address the degree of satisfaction with 
physically expressing aff ection; the variety of sexual ac-
tivities engaged in; and with the sexual relationship in 
general. Th e fourth item addresses the perceived level 
of satisfaction experienced by the partner within the 
relationship. Th is four-item scale is one of the compo-
nents of the Multiple Sclerosis Quality of life (MSQ-
LI). Raw scores on the 4 sexual satisfaction items 
(items 2-5) are summed to create total score. Th us, this 
scale can range from 4 to 24. Higher scores indicate 
greater problems with sexual satisfaction.
Th e Beck Depression Inventory (BDI, BDI-II), 
created by Dr. Aaron T. Beck, is a 21-question multi-
ple-choice self-report inventory that is one of the most 
widely used instruments for measuring the severity of 
depression. Th e latest version of the questionnaire is 
designed for individuals aged 13 and over and is com-
posed of items relating to depression symptoms such 
as hopelessness and irritability, cognitions such as guilt 
or feelings of being punished, as well as physical symp-
toms such as fatigue, weight loss, and lack of interest in 
sex. Th ere are three versions of the BDI: the original 
BDI fi rst published in 1961 and later revised in 1971 
as BDI-1A, and the BDI-II published in 1996. Like 
BDI, the BDI-II also contains 21 questions, each an-
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swer being scored on a scale of 0 to 3. Th e cutoff s used 
diff er from the original: 0-13 = minimal depression; 
14-19 = mild depression; 20-28 = moderate depres-
sion; and 29-63 = severe depression. Higher total 
scores indicate more severe depressive symptoms.
Th e Expanded Disability Status Scale (EDSS) is 
evaluating the degree of neurologic impairment in 
MS; it is a combination of grades (0 = normal to 5 or 6 
= maximal impairment) within 8 Functional Systems 
(FS) and an overall Disability Status Scale (DSS) 
that have steps from 0 (normal) to 10 (death due to 
MS). Th e FS are Pyramidal, Cerebellar, Brain Stem, 
Sensory, Bowel & Bladder, Visual, Cerebral (Mental). 
Total EDSS score varies from 0-normal to 10-death 
due to MS.
Th e research was approved by the Sestre milosrd-
nice University Hospital Center Ethics Committee. 
All patients signed the informed consent form for par-
ticipation in the study, as well as permission for pub-
lishing the data.
Results
All patients were in the group with EDSS 2 to 4 
points (fully ambulatory patients) and all were young 
adults (interval 23-47 years). Th ere were 42 men and 
56 women. Duration of the disease was 5±1.5 years. 
According to the level of education, there were 45% of 
patients with university degree, 37% with secondary 
school and 18% with elementary school. Most of the 
patients were single or divorced (no statistically sig-
nifi cant diff erences according to gender; p>0.05). De-
spite low EDSS score, only 23% of study patients were 
working full time, whereas almost two-thirds were 
working half time or retired/unemployed (Table 1). 
Th ere was no statistically signifi cant diff erence in BDS 
and SSS values according to gender, disease duration 
or immunomodulatory therapy (p>0.05).
Symptoms of depression were identifi ed in 57% of 
patients (no gender diff erences; p>0.05), and symptoms 
of SD in 71% of patients (no gender diff erences; 
p>0.05). Most of men reported erectile dysfunction 
(31%), while the lack of sexual desire (20%) and orgasm 
problems (13%) were less frequently reported. In wom-
en, the lack of sexual desire was mostly frequently re-
ported (25%), while orgasm problems (21%) and lubri-
cation problems (20%) were less frequently reported.
Th e Beck Depression Scale score for both men and 
women was in the range for mild depression, and SSS 
score in the range for moderate SD (no diff erences ac-
cording to gender; p>0.05).
Chronic fatigue was identifi ed n 64% (no gender 
diff erences), bladder and sphincter control disturbanc-
es in 34% (no gender diff erences), and spasticity in 
42% of patients (no gender diff erences) (p>0.05 all).
Table 2. Depression symptoms and sexual dysfunction 
scores of multiple sclerosis patients









Scale correlation coeffi  cient
Men 0.42 
Women 0.44 











(number of patients; percent)
Elementary school 17 (18%)
Secondary school 36 (37%) 
University 45 (45%)
Marital status





(number of patients; percent)
Retired/unemployed 25 (25.5)
Half time 50 (50.7)
Full time 23 (23.6)
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Th ere was no statistically signifi cant diff erence in 
BDS and SSS values according to EDSS score 
(p>0.05). Correlation coeffi  cients were calculated 
(BDS and SSS) for men (p=0.42) and for women 
(p=0.44), yielding positive correlation (Table 2).
Discussion
Our study patients were young adults aged 23-47 
and mobile, with EDSS score 2-4. Only one-third of 
patients were married and one-third had full time 
working hours. Th e incidence of depression was slight-
ly higher in our study than in previous studies (57% vs. 
50%), and SD was present at a high percentage, but 
not higher than in other studies (71% vs. 40%-75%). 
Th ese data indicate that despite low EDSS functional 
score which refl ects direct and indirect physical impact 
on SD, there is a high emotional and cultural infl uence 
on SD12,13.
We found positive correlation for both genders be-
tween depression and SD. Miscellaneous factors are 
involved in the incidence of depression and SD in MS 
patients. According to large studies, there does not ap-
pear to be clear genetic predisposition for major de-
pression and SD in MS patients. Structural changes 
confi rmed on MRI of the brain and spine are in cor-
relation with previously described pathomorphologi-
cal and functional mechanisms of depression and SD. 
Psychosocial factors are of great importance in the 
evaluation of depression and SD in MS patients. A 
major limiting factor is that studies evaluating the im-
pact of these factors are cross sectional, lacking follow 
up data10-12. Results of these studies have shown that 
the most important problem in the evaluation and 
treatment of MS patients with depression and SD is 
focus on emotion/state rather than the problem that 
has caused it. In order to resolve depressive mood and 
SD, a multidisciplinary approach should be used. Th e 
evaluation and treatment should also include func-
tional status of the patient (EDSS score), as well as 
individual approach in planning medical treatment of 
MS, symptomatic treatment (bladder and sphincter 
control, pain, spasms) and coping strategies, recre-
ational opportunities, improvement of relationships, 
and reduction of physical and psychical stress (chronic 
fatigue). In addition, it is of great importance to take in 
consideration disturbances of the hypothalamic-pitu-
itary-adrenal axis, as well as the hypothalamic-pitu-
itary-gonadal axis with disturbances of mood (depres-
sive disorder) and SD as consequences13.
Despite pronounced depression in MS patients, 
there are few well constructed psychopharmacological 
studies (the Cochrane Multiple Sclerosis Group’s Trial 
Register contains only 2 studies the methodology of 
which, i.e. randomized, controlled, double blinded 
study, is considered appropriate). In these two studies, 
tricyclic antidepressants and serotonin reuptake in-
hibitors (SSRI) were proven to have positive impact 
on regression of depressive symptoms in MS patients 
versus placebo group. On subsequent screenings, pa-
tients reported fewer depressive symptoms regardless 
of whether a formal treatment recommendation was 
documented. Th ese fi ndings suggest that while depres-
sion screening does lead to depression related inter-
vention in many cases, additional research is necessary 
to determine who is most likely to benefi t and under 
what conditions13,14.
In the evaluation of MS patients, depression and 
SD symptoms should be evaluated and appropriately 
treated with individual, but also multidisciplinary ap-
proach in order to improve their quality of life. Th ere is 
a need of follow up studies to evaluate the impact of 
diff erent physical, functional and psychosocial factors, 
as well as the impact of rehabilitation, immunomodu-
latory therapy and symptomatic therapy on long term 
outcome and quality of life in MS patients14-16.
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Sažetak
SEKSUALNA DISFUNKCIJA I INCIDENCIJA DEPRESIJE 
U BOLESNIKA S MULTIPLOM SKLEROZOM
I. Zavoreo, T. Gržinčić, M. Preksavec i V. Bašić Kes
Multipla skleroza (MS) je jedna od najčešćih bolesti središnjeg živčanog sustava, a najčešće se javlja u mlađoj životnoj 
dobi kada su bolesnici seksualno aktivni. U svakodnevnoj praksi seksualna disfunkcija biva podcijenjena jer se kliničari uglav-
nom fokusiraju na klasične neurološke ispade te najčešće ne prepoznaju simptome koji mogu značajno umanjiti kvalitetu 
života bolesnika. U našu studiju je bilo uključeno 98 bolesnika (42 muškarca i 56 žena, srednje dobi 35±12 godina) s dijagno-
sticiranim relaps remitentnim oblikom multiple skleroze prema McDonaldovim kriterijima. Bolesnici su ispunili standar-
dizirane upitnike (Sexual Satisfaction Scale, SSS i Beck Depression Scale, BDS) kako bi se procijenile depresivne tegobe i 
 seksualna disfunkcija, a provedeno je i neurološko testiranje pomoću funkcijske ocjenske skale (Expanded Disability Status 
Scale, EDSS). Svi bolesnici su bili pokretni i imali EDSS zbroj između 2 i 4. Nije bilo razlike u BDS i SSS vrijednostima u 
odnosu na EDSS zbroj. Koefi cijenti korelacije za BDS i SSS su izračunati za muškarce (p=0,42) i žene (p=0,44) i pokazali su 
pozitivnu korelaciju. Nije nađeno statistički značajnih razlika za BDS i SSS vrijednosti u odnosu na spol, duljinu trajanja 
bolesti te vrstu imunomodulacijske terapije. U našoj skupini ispitanika, unatoč niskom EDSS zbroju (pokretni bolesnici, 
sposobni se brinuti o sebi) nađena je pozitivna korelacija između depresije i seksualne disfunkcije, što ukazuje da i u takvih 
bolesnika kvaliteta života može biti znatno narušena. Možemo zaključiti kako su seksualna disfunkcija i depresija neki od 
najčešće podcijenjenih simptoma od strane neurologa jer nisu dio rutinskih testiranja. Potrebno je u rutinsku evaluaciju 
 bolesnika s MS uključiti dodatne upitnike kako bi se procijenila kvaliteta života bez obzira na njihov EDSS zbroj.
Ključne riječi: Multipla skleroza; Spolna disfunkcija, fi ziološka; Spolna disfunkcija, psihološka; Depresija
